Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Number of holders
-
36
-
Total 13F principal, excl. options
-
209M
-
Principal change
-
-110M
-
Total reported value, excl. options
-
$177M
-
Value change
-
-$103M
-
Number of buys
-
16
-
Number of sells
-
-9
-
Price
-
$0.99
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2022
43 filings reported holding 09061GAK7 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2022.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 has 36 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $209M of principal
.
Largest 10 bondholders include Voya Investment Management LLC ($130M of principal), MACKAY SHIELDS LLC ($77M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($33.5M of principal), Thrivent Financial for Lutherans ($16M of principal), STATE STREET CORP ($14.7M of principal), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($13.7M of principal), Jefferies Group LLC ($8.31M of principal), Invesco Ltd. ($6.8M of principal), NEW YORK STATE COMMON RETIREMENT FUND ($5.43M of principal), and BlackRock Inc. ($5.23M of principal).
This table shows the top 36 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.